Prof. Dr. Shaban Y. Shaban is a professor of bioinorganic chemistry at the Faculty of Science, Kafrelsheikh University, Egypt. He earned his Ph.D. from the University of Erlangen–Nuremberg, Germany, and has developed an internationally recognized research program in bioinorganic chemistry, pharmaceutical nanotechnology, and targeted drug delivery. His research focuses on stimuli-responsive nanocarriers, chitosan-based nanocomposites, metal complexes, biomimetic catalysis, and nanomedicine for cancer and viral disease treatment. He has published more than 70 peer-reviewed articles and collaborates extensively with scientists in Germany, Saudi Arabia, Poland, Japan, and Egypt. His work integrates synthetic chemistry, advanced kinetics, molecular docking, and mechanistic studies to develop innovative therapeutic and functional materials. Prof. Shaban's contributions have led to highly cited publications in drug delivery, nanocomposite technology, and biomimetic catalysis, establishing him as a leading researcher in the intersection of inorganic chemistry and biomedical applications
Prof. Dr. Shaban Y. Shaban is a professor of bioinorganic chemistry at the Faculty of Science, Kafrelsheikh University, Egypt. He earned his Ph.D. from the University of Erlangen–Nuremberg, Germany, and has developed an internationally recognized research program in bioinorganic chemistry, pharmaceutical nanotechnology, and targeted drug delivery. His research focuses on stimuli-responsive nanocarriers, chitosan-based nanocomposites, metal complexes, biomimetic catalysis, and nanomedicine for cancer and viral disease treatment. He has published more than 70 peer-reviewed articles and collaborates extensively with scientists in Germany, Saudi Arabia, Poland, Japan, and Egypt. His work integrates synthetic chemistry, advanced kinetics, molecular docking, and mechanistic studies to develop innovative therapeutic and functional materials. Prof. Shaban's contributions have led to highly cited publications in drug delivery, nanocomposite technology, and biomimetic catalysis, establishing him as a leading researcher in the intersection of inorganic chemistry and biomedical applications